Professor Pranela Rameshwar obtained her education at the University of Wisconsin-Madison, WI, USA and Rutger's University, Newark, New Jersey, USA. Her main academic appointment is at Rutgers-New Jersey Medical School, Department of Medicine-Hematology/Oncology.
Mr. Adam Mostafa is the Chief Financial Officer at Abpro Corporation. Before Abpro, Mr. Mostafa served as Managing Director of Healthcare Investment Banking Group at Cantor Fitzgerald, L.P with responsibility for origination of life sciences transactions (FOs, Debt, IPOs, M&A).
Philip B. Schoettle, MD, PhD, currently serves as Senior Medical Director of the Knee and Hip Institute Munich, a private institute for orthopedics, sports, and orthobiology. He is also a cell therapy surgeon and orthopedic specialist at Okyanos Center for Regenerative Medicine.
As one of the nation’s leading physicians, Daniel D. Karp, MD brings a wealth of clinical and research expertise in both oncology and hematology. Recognized as one of the leading oncologists in the world, Dr. Karp is currently Medical Director of the Clinical Translational Research Center (CTRC) at The University of Texas MD Anderson Cancer Center in Houston.